Suppr超能文献

残余肾功能与腹膜透析相关性腹膜炎治疗结局。

Residual Kidney Function and Peritoneal Dialysis-Associated Peritonitis Treatment Outcomes.

机构信息

Laboratory Medicine Program.

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; and.

出版信息

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2016-2022. doi: 10.2215/CJN.00630117. Epub 2017 Nov 7.

Abstract

BACKGROUND AND OBJECTIVES

Residual kidney function contributes to the clearance of antibiotics excreted by the kidneys, lowering the antibiotic concentration, which may adversely affect the treatment of peritoneal dialysis-associated peritonitis. The objective of our study was to examine the relationship between residual kidneyfunction and peritonitis treatment outcomes.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our study included 181 participants who experienced 339 episodes of Gram-positive, Gram-negative, and culture-negative peritoneal dialysis-associated peritonitis at a single centerfrom 2003 to 2010. Episodes were categorized according to participants' urinary creatinine clearance (0, >0-5, and >5 ml/min). The data were analyzed using generalized estimating equation models to determine the covariate-adjusted association between urinary creatinine clearance and treatment failure (defined as relapse or recurrent peritonitis episodes, peritoneal catheter removal, or death from any cause during peritonitis treatment).

RESULTS

Among episodes of peritonitis due to Gram-positive organisms or culture-negative infections, those experienced by participants with urinary creatinine clearance >5 ml/min had significantly higher odds of treatment failure than episodes experienced by anuric participants (27 of 80 versus 20 of 119 episodes resulting in treatment failure for creatinine clearance >5 versus 0 ml/min; odds ratio, 6.80; 95% confidence interval, 2.37 to 19.6). Episodes experienced by participants with creatinine clearance >0-5 ml/min also had significantly higher odds of treatment failure than episodes experienced by anuric participants (14 of 64 episodes resulting in treatment failure for creatinine clearance >0-5 ml/min; odds ratio, 2.87; 95% confidence interval, 1.12 to 7.35). The odds of relapse and recurrent peritonitis among participants with creatinine clearance >5 ml/min was also significantly higher compared with in anuric participants (17 of 80 versus 12 of 119 episodes resulting in relapse and recurrence for creatinine clearance >5 versus 0 ml/min; odds ratio, 6.76; 95% confidence interval, 1.90 to 23.8). Among participants with Gram-negative peritonitis, creatinine clearance was significantly associated with neither treatment failure nor relapse and recurrent peritonitis.

CONCLUSIONS

Residual kidney function as measured by greater urinary creatinine clearance was associated with treatment failure among participants with Gram-positive and culture-negative peritonitis.

摘要

背景与目的

残余肾功能有助于清除肾脏排泄的抗生素,降低抗生素浓度,这可能会对腹膜透析相关性腹膜炎的治疗产生不利影响。本研究的目的是研究残余肾功能与腹膜炎治疗结局之间的关系。

设计、地点、参与者和测量方法:本研究纳入了 2003 年至 2010 年期间在一家中心因革兰阳性菌、革兰阴性菌和培养阴性的腹膜透析相关性腹膜炎而接受治疗的 181 名参与者的 339 例腹膜炎发作。根据参与者的尿肌酐清除率(0、>0-5 和>5ml/min)将发作进行分类。使用广义估计方程模型分析数据,以确定尿肌酐清除率与治疗失败(定义为复发或复发性腹膜炎发作、腹膜导管拔除或腹膜炎治疗期间任何原因导致的死亡)之间的协变量调整关联。

结果

在革兰阳性菌或培养阴性感染引起的腹膜炎发作中,尿肌酐清除率>5ml/min 的参与者的治疗失败发生率明显高于无尿参与者(27/80 例与 20/119 例治疗失败;肌酐清除率>5 与 0ml/min;优势比,6.80;95%置信区间,2.37 至 19.6)。尿肌酐清除率>0-5ml/min 的参与者的治疗失败发生率也明显高于无尿参与者(肌酐清除率>0-5ml/min 的 64 例发作中有 14 例治疗失败;优势比,2.87;95%置信区间,1.12 至 7.35)。尿肌酐清除率>5ml/min 的参与者的复发和复发性腹膜炎的几率也明显高于无尿参与者(27/80 例与 20/119 例治疗失败;肌酐清除率>5 与 0ml/min;优势比,6.76;95%置信区间,1.90 至 23.8)。对于革兰阴性腹膜炎患者,肌酐清除率与治疗失败或复发和复发性腹膜炎均无显著相关性。

结论

用较大的尿肌酐清除率衡量的残余肾功能与革兰阳性和培养阴性腹膜炎患者的治疗失败相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验